Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0QCO stock hub

LON/0QCO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QCOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

672.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QCO

In the news

Latest news · LON/0QCO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.5

P25 n/aP50 n/aP75 n/a

Trailing P/E71.9

P25 n/aP50 n/aP75 n/a

ROE5

P25 n/aP50 n/aP75 n/a

ROIC10

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QCO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	UK
Employees	407
Employees Change	22%
Employees Change Percent	5.76
Enterprise value	EUR 632.5M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 672.9M
Price	EUR 1.09
Price currency	EUR
Rev Per Employee	687,504.55x
Sic	2836
Symbol	lon/0QCO
Website	https://www.pharming.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.39%
EV Earnings	67.58x
EV/EBIT	23.86x
EV/EBITDA	19.74x
EV/FCF	14.99x
EV/Sales	2.28x
FCF yield	6.27%
Forward P/E	19.47x
P/B ratio	3.3x
P/E ratio	71.91x
P/S ratio	2.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.44%
EBITDA Margin	11.44%
FCF margin	15.08%
Gross margin	88.14%
Gross Profit	EUR 246.6M
Gross Profit Growth	14.12%
Gross Profit Growth Q	-7.02%
Gross Profit Growth3 Y	20.79%
Gross Profit Growth5 Y	12.61%
Net Income	EUR 9.4M
Net Income Growth5 Y	-19.76%
Pretax Margin	5.38%
Profit Margin	3.34%
Profit Per Employee	EUR 22,993
ROA	4.89
Roa5y	1.24
ROCE	9.25
ROE	5.04
Roe5y	1.21
ROIC	10
Roic5y	1.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.67%
Cagr15y	-4.92%
Cagr1y	42.16%
Cagr3y	0.83%
Cagr5y	0.3%
EPS Growth5 Y	-22.02
FCF Growth	994.32%
FCF Growth5 Y	-2.9%
OCF Growth	827.48%
OCF Growth Q	741.38%
OCF Growth5 Y	-4.37%
Revenue Growth	15.21x
Revenue Growth Q	-8.4x
Revenue Growth3 Y	22.39x
Revenue Growth5 Y	12.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.83
Assets	EUR 370.6M
Cash	EUR 128.9M
Current Assets	EUR 216.8M
Current Liabilities	EUR 82.4M
Debt	EUR 88M
Debt EBITDA	EUR 2.75
Debt Equity	EUR 0.43
Debt FCF	EUR 2.09
Equity	EUR 203.7M
Interest Coverage	3.25
Liabilities	EUR 166.9M
Long Term Assets	EUR 153.8M
Long Term Liabilities	EUR 84.5M
Net Cash	EUR 40.9M
Net Cash By Market Cap	EUR 6.07
Net Debt EBITDA	EUR -1.28
Net Debt Equity	EUR -0.2
Net Debt FCF	EUR -0.97
Tangible Book Value	EUR 104.5M
Tangible Book Value Per Share	EUR 0.14
WACC	5.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.63
Inventory Turnover	0.71
Net Working Capital	EUR 16M
Quick ratio	2.05
Working Capital	EUR 138.7M
Working Capital Turnover	EUR 1.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	328.6%
1Y total return	42.12%
200-day SMA	1.33
3Y total return	2.5%
50-day SMA	1.4
50-day SMA vs 200-day SMA	50over200
5Y total return	1.49%
All Time High	4
All Time High Change	-72.77%
All Time High Date	2010-03-15
All Time Low	0.09
All Time Low Change	1,181.2%
All Time Low Date	2013-05-22
ATR	0.08
Beta	0.12
Ch YTD	-23.58
High	1.11
High52	1.83
High52 Date	2026-01-28
High52ch	-40.39%
Low	1.03
Low52	0.81
Low52 Date	2025-05-08
Low52ch	35.2%
Ma50ch	-22.1%
Price vs 200-day SMA	-18.18%
RSI	24.18
RSI Monthly	48.35
RSI Weekly	38.28
Sharpe ratio	0.59x
Sortino ratio	0.92
Total Return	-13.48%
Tr YTD	-23.56
Tr15y	-53.11%
Tr1m	-24.5%
Tr1w	-23.76%
Tr3m	-20.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 26.4M
Operating Income Growth	158.9
Operating Income Growth5 Y	-10.75
Operating margin	9.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	695,284,727%
Net Borrowing	-12,106,648.6
Shares Insiders	1.55%
Shares Institutions	22.84%
Shares Qo Q	-1.64%
Shares Yo Y	13.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 31.3M
Average Volume	1,141,466.55x
Bv Per Share	0.27
CAPEX	EUR -533,900
Ch10y	325.4
Ch15y	-53.46
Ch1m	-24.48
Ch1w	-23.74
Ch1y	42.11
Ch3m	-20.45
Ch3y	2.45
Ch5y	1.49
Ch6m	-20.45
Change	4.16%
Change From Open	3.25
Close	1.05
Days Gap	0.89
Depreciation Amortization	5,422,869
Dollar Volume	4,704,288.7
Earnings Date	2026-05-07
EBIT	EUR 26.4M
EBITDA	EUR 32M
EPS	EUR 0.01
F Score	5
FCF	EUR 42.2M
FCF EV Yield	6.67x
Financing CF	-763,363
Fiscal Year End	December
Founded	1,988
Graham Number	0.33516
Graham Upside	-69.22
Income Tax	EUR 5.8M
Investing CF	-51,647,444
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2013-03-05
Last Split Type	Reverse
Lynch Fair Value	EUR 0.08
Lynch Upside	-93.05
Ma150	1.4
Ma150ch	-22.1%
Ma20	1.42
Ma20ch	-23.15%
Net CF	-5,841,851
Next Earnings Date	2026-07-30
Open	1.05
P FCF Ratio	15.95
P OCF Ratio	15.75
Position In Range	75.02
Ppne	16,942,706.4
Price Date	2026-05-08
Price EBITDA	EUR 21.01
Ptbv Ratio	6.44
Relative Volume	3.78x
Revenue	279,814,353x
SBC By Revenue	3.9x
Share Based Comp	10,916,552
Tax By Revenue	2.08x
Tax Rate	38.57%
Tr6m	-20.46%
Volume	4,319,745

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0QCO pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0QCO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QCO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.8%

Share of float held by funds and institutions

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.5%

Negative means the company is buying back shares.

Technical

LON/0QCO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.2

Below 30: short-term oversold

Price vs 200-day MA

-18.2%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QCO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QCO stock rating?

lon/0QCO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QCO analysis?

The full report lives at /stocks/lon/0QCO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QCO?

The latest report frames lon/0QCO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QCO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.